Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on November 17, 2003

Circulation. 2003
Published online before print November 17, 2003, doi: 10.1161/01.CIR.0000096489.40209.DD
A more recent version of this article appeared on November 25, 2003
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
108/21/2716    most recent
01.CIR.0000096489.40209.DDv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pellis, T.
Right arrow Articles by Checchia, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pellis, T.
Right arrow Articles by Checchia, P.
Related Collections
Right arrow CPR and emergency cardiac care

Submitted on March 18, 2003
Revised on July 23, 2003
Accepted on July 26, 2003

Evidence Favoring the Use of an {alpha}2-Selective Vasopressor Agent for Cardiopulmonary Resuscitation

Tommaso Pellis MD, Max Harry Weil MD, PhD*, Wanchun Tang MD, Shijie Sun MD, Jing Xie MD, Lei Song MD, and Paul Checchia MD

From the Institute of Critical Care Medicine, Palm Springs, Calif (T.P., M.H.W., W.T., S.S., J.X., L.S.); the Keck School of Medicine of the University of Southern California, Los Angeles (M.H.W., W.T., S.S.); and Loma Linda University Medical Center, Loma Linda, Calif (P.C.).

* To whom correspondence should be addressed. E-mail: weilm{at}911research.org.

Background--Both {alpha}1- and {beta}-adrenergic agonists increase the severity of global myocardial ischemic injury. We hypothesized that combined {beta}- and {alpha}1-adrenergic blockade would improve initial resuscitation and postresuscitation myocardial and neurological functions. We further hypothesized that the resulting {alpha}2-actions of relatively brief duration would favor improved functions compared with the more prolonged effect of nonadrenergic vasopressin.

Methods and Results--Three groups of 5 male domestic pigs weighing 37±3 kg were investigated. Ventricular fibrillation was untreated for 7 minutes before the start of precordial compression, mechanical ventilation, and attempted defibrillation. Animals were randomized to receive central venous injections of equipressor doses of (1) epinephrine, (2) epinephrine in which both {alpha}1- and {beta}-adrenergic effects were blocked by previous administration of prazosin and propranolol, and (3) vasopressin during CPR. All but 1 animal were successfully resuscitated. After injection of epinephrine, significantly better cardiac output and fractional area change, together with lesser increases in troponin I, were observed after {alpha}1- and {beta}-adrenergic blockade. Postresuscitation neurological function was also improved after {alpha}1- and {beta}-block in comparison with unblocked epinephrine and after vasopressin.

Conclusions--Equipressor doses of epinephrine, epinephrine after {alpha}1- and {beta}-adrenergic blockade, and vasopressin were equally effective in restoring spontaneous circulation after prolonged ventricular fibrillation. However, combined {alpha}1- and {beta}-adrenergic blockade, which represented a predominantly selective {alpha}2-vasopressor effect, resulted in improved postresuscitation cardiac and neurological recovery.


Key words: cardiopulmonary resuscitation • epinephrine • receptors, adrenergic, alpha • receptors, adrenergic, beta • vasopressin




This article has been cited by other articles:


Home page
J CARDIOVASC PHARMACOL THERHome page
L. Huang, M. H. Weil, S. Sun, W. Tang, and X. Fang
Carvedilol Mitigates Adverse Effects of Epinephrine During Cardiopulmonary Resuscitation
Journal of Cardiovascular Pharmacology and Therapeutics, April 1, 2005; 10(2): 113 - 120.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
A. M. Zafari, S. K. Zarter, V. Heggen, P. Wilson, R. A. Taylor, K. Reddy, A. G. Backscheider, and S. C. Dudley Jr
A program encouraging early defibrillation results in improved in-hospital resuscitation efficacy
J. Am. Coll. Cardiol., August 18, 2004; 44(4): 846 - 852.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Sun, M. H. Weil, W. Tang, T. Kamohara, and K. Klouche
{delta}-Opioid receptor agonist reduces severity of postresuscitation myocardial dysfunction
Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H969 - H974.
[Abstract] [Full Text] [PDF]